أرسل هذا في رسالة قصيرة: Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

  _____      ___     _    _      ___      ______  
 |__  //    / _ \\  | |  | ||   / _ \\   /_   _// 
   / //    | / \ || | |/\| ||  | / \ ||    | ||   
  / //__   | \_/ || |  /\  ||  | \_/ ||   _| ||   
 /_____||   \___//  |_// \_||   \___//   /__//    
 `-----`    `---`   `-`   `-`   `---`    `--`